Global Immuno-Oncology Treatment Market Size, Status and Forecast 2024-2031

Report ID: 920475 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Immune Checkpoint Inhibitors
        1.2.3 Monoclonal Antibodies
        1.2.4 Cytokine-Based Immunotherapy
        1.2.5 Cancer Vaccines
        1.2.6 CAR-T Cell Therapy
    1.3 Market by Application
        1.3.1 Global Immuno-Oncology Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Center
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Immuno-Oncology Treatment Market Perspective (2016-2027)
    2.2 Immuno-Oncology Treatment Growth Trends by Regions
        2.2.1 Immuno-Oncology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Immuno-Oncology Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Immuno-Oncology Treatment Industry Dynamic
        2.3.1 Immuno-Oncology Treatment Market Trends
        2.3.2 Immuno-Oncology Treatment Market Drivers
        2.3.3 Immuno-Oncology Treatment Market Challenges
        2.3.4 Immuno-Oncology Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Immuno-Oncology Treatment Players by Revenue
        3.1.1 Global Top Immuno-Oncology Treatment Players by Revenue (2016-2021)
        3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Immuno-Oncology Treatment Revenue
    3.4 Global Immuno-Oncology Treatment Market Concentration Ratio
        3.4.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2020
    3.5 Immuno-Oncology Treatment Key Players Head office and Area Served
    3.6 Key Players Immuno-Oncology Treatment Product Solution and Service
    3.7 Date of Enter into Immuno-Oncology Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Oncology Treatment Breakdown Data by Type
    4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2022-2027)

5 Immuno-Oncology Treatment Breakdown Data by Application
    5.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Immuno-Oncology Treatment Market Size (2016-2027)
    6.2 North America Immuno-Oncology Treatment Market Size by Type
        6.2.1 North America Immuno-Oncology Treatment Market Size by Type (2016-2021)
        6.2.2 North America Immuno-Oncology Treatment Market Size by Type (2022-2027)
        6.2.3 North America Immuno-Oncology Treatment Market Size by Type (2016-2027)
    6.3 North America Immuno-Oncology Treatment Market Size by Application
        6.3.1 North America Immuno-Oncology Treatment Market Size by Application (2016-2021)
        6.3.2 North America Immuno-Oncology Treatment Market Size by Application (2022-2027)
        6.3.3 North America Immuno-Oncology Treatment Market Size by Application (2016-2027)
    6.4 North America Immuno-Oncology Treatment Market Size by Country
        6.4.1 North America Immuno-Oncology Treatment Market Size by Country (2016-2021)
        6.4.2 North America Immuno-Oncology Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Immuno-Oncology Treatment Market Size (2016-2027)
    7.2 Europe Immuno-Oncology Treatment Market Size by Type
        7.2.1 Europe Immuno-Oncology Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Immuno-Oncology Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Immuno-Oncology Treatment Market Size by Type (2016-2027)
    7.3 Europe Immuno-Oncology Treatment Market Size by Application
        7.3.1 Europe Immuno-Oncology Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Immuno-Oncology Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Immuno-Oncology Treatment Market Size by Application (2016-2027)
    7.4 Europe Immuno-Oncology Treatment Market Size by Country
        7.4.1 Europe Immuno-Oncology Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Immuno-Oncology Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Immuno-Oncology Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Type
        8.2.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Application
        8.3.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
        8.4.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Immuno-Oncology Treatment Market Size (2016-2027)
    9.2 Latin America Immuno-Oncology Treatment Market Size by Type
        9.2.1 Latin America Immuno-Oncology Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Immuno-Oncology Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Immuno-Oncology Treatment Market Size by Type (2016-2027)
    9.3 Latin America Immuno-Oncology Treatment Market Size by Application
        9.3.1 Latin America Immuno-Oncology Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Immuno-Oncology Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Immuno-Oncology Treatment Market Size by Application (2016-2027)
    9.4 Latin America Immuno-Oncology Treatment Market Size by Country
        9.4.1 Latin America Immuno-Oncology Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Immuno-Oncology Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Immuno-Oncology Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type
        10.2.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Application
        10.3.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
        10.4.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Immuno-Oncology Treatment Introduction
        11.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.1.5 Amgen Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
        11.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.2.5 AstraZeneca Recent Development
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Company Details
        11.3.2 Bristol-Myers Squibb Business Overview
        11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
        11.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.3.5 Bristol-Myers Squibb Recent Development
    11.4 Eli-Lilly
        11.4.1 Eli-Lilly Company Details
        11.4.2 Eli-Lilly Business Overview
        11.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
        11.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.4.5 Eli-Lilly Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Immuno-Oncology Treatment Introduction
        11.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.5.5 Roche Recent Development
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Details
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
        11.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.6.5 GlaxoSmithKline Recent Development
    11.7 Janssen Biotech
        11.7.1 Janssen Biotech Company Details
        11.7.2 Janssen Biotech Business Overview
        11.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
        11.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.7.5 Janssen Biotech Recent Development
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Immuno-Oncology Treatment Introduction
        11.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.8.5 Merck Recent Development
    11.9 Novartis
        11.9.1 Novartis Company Details
        11.9.2 Novartis Business Overview
        11.9.3 Novartis Immuno-Oncology Treatment Introduction
        11.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.9.5 Novartis Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Immuno-Oncology Treatment Introduction
        11.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.10.5 Pfizer Recent Development
    11.11 Sanofi
        11.11.1 Sanofi Company Details
        11.11.2 Sanofi Business Overview
        11.11.3 Sanofi Immuno-Oncology Treatment Introduction
        11.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.11.5 Sanofi Recent Development
    11.12 Spectrum Pharmaceuticals
        11.12.1 Spectrum Pharmaceuticals Company Details
        11.12.2 Spectrum Pharmaceuticals Business Overview
        11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
        11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.12.5 Spectrum Pharmaceuticals Recent Development
    11.13 Takeda
        11.13.1 Takeda Company Details
        11.13.2 Takeda Business Overview
        11.13.3 Takeda Immuno-Oncology Treatment Introduction
        11.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2016-2021)
        11.13.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Immune Checkpoint Inhibitors
    Table 3. Key Players of Monoclonal Antibodies
    Table 4. Key Players of Cytokine-Based Immunotherapy
    Table 5. Key Players of Cancer Vaccines
    Table 6. Key Players of CAR-T Cell Therapy
    Table 7. Global Immuno-Oncology Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Immuno-Oncology Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Immuno-Oncology Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Immuno-Oncology Treatment Market Share by Regions (2016-2021)
    Table 11. Global Immuno-Oncology Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Immuno-Oncology Treatment Market Share by Regions (2022-2027)
    Table 13. Immuno-Oncology Treatment Market Trends
    Table 14. Immuno-Oncology Treatment Market Drivers
    Table 15. Immuno-Oncology Treatment Market Challenges
    Table 16. Immuno-Oncology Treatment Market Restraints
    Table 17. Global Immuno-Oncology Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Immuno-Oncology Treatment Market Share by Players (2016-2021)
    Table 19. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology Treatment as of 2020)
    Table 20. Ranking of Global Top Immuno-Oncology Treatment Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Immuno-Oncology Treatment Product Solution and Service
    Table 24. Date of Enter into Immuno-Oncology Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Immuno-Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Immuno-Oncology Treatment Revenue Market Share by Type (2016-2021)
    Table 28. Global Immuno-Oncology Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Immuno-Oncology Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Immuno-Oncology Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Immuno-Oncology Treatment Revenue Market Share by Application (2016-2021)
    Table 32. Global Immuno-Oncology Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Immuno-Oncology Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Immuno-Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Immuno-Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Immuno-Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Immuno-Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Immuno-Oncology Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Immuno-Oncology Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Immuno-Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Immuno-Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Immuno-Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Immuno-Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Immuno-Oncology Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Immuno-Oncology Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Immuno-Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Immuno-Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Immuno-Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Immuno-Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Immuno-Oncology Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Immuno-Oncology Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Amgen Company Details
    Table 65. Amgen Business Overview
    Table 66. Amgen Immuno-Oncology Treatment Product
    Table 67. Amgen Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 68. Amgen Recent Development
    Table 69. AstraZeneca Company Details
    Table 70. AstraZeneca Business Overview
    Table 71. AstraZeneca Immuno-Oncology Treatment Product
    Table 72. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 73. AstraZeneca Recent Development
    Table 74. Bristol-Myers Squibb Company Details
    Table 75. Bristol-Myers Squibb Business Overview
    Table 76. Bristol-Myers Squibb Immuno-Oncology Treatment Product
    Table 77. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 78. Bristol-Myers Squibb Recent Development
    Table 79. Eli-Lilly Company Details
    Table 80. Eli-Lilly Business Overview
    Table 81. Eli-Lilly Immuno-Oncology Treatment Product
    Table 82. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 83. Eli-Lilly Recent Development
    Table 84. Roche Company Details
    Table 85. Roche Business Overview
    Table 86. Roche Immuno-Oncology Treatment Product
    Table 87. Roche Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 88. Roche Recent Development
    Table 89. GlaxoSmithKline Company Details
    Table 90. GlaxoSmithKline Business Overview
    Table 91. GlaxoSmithKline Immuno-Oncology Treatment Product
    Table 92. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 93. GlaxoSmithKline Recent Development
    Table 94. Janssen Biotech Company Details
    Table 95. Janssen Biotech Business Overview
    Table 96. Janssen Biotech Immuno-Oncology Treatment Product
    Table 97. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 98. Janssen Biotech Recent Development
    Table 99. Merck Company Details
    Table 100. Merck Business Overview
    Table 101. Merck Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 102. Merck Recent Development
    Table 103. Novartis Company Details
    Table 104. Novartis Business Overview
    Table 105. Novartis Immuno-Oncology Treatment Product
    Table 106. Novartis Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 107. Novartis Recent Development
    Table 108. Pfizer Company Details
    Table 109. Pfizer Business Overview
    Table 110. Pfizer Immuno-Oncology Treatment Product
    Table 111. Pfizer Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 112. Pfizer Recent Development
    Table 113. Sanofi Company Details
    Table 114. Sanofi Business Overview
    Table 115. Sanofi Immuno-Oncology Treatment Product
    Table 116. Sanofi Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 117. Sanofi Recent Development
    Table 118. Spectrum Pharmaceuticals Company Details
    Table 119. Spectrum Pharmaceuticals Business Overview
    Table 120. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product
    Table 121. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 122. Spectrum Pharmaceuticals Recent Development
    Table 123. Takeda Company Details
    Table 124. Takeda Business Overview
    Table 125. Takeda Immuno-Oncology Treatment Product
    Table 126. Takeda Revenue in Immuno-Oncology Treatment Business (2016-2021) & (US$ Million)
    Table 127. Takeda Recent Development
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immuno-Oncology Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Immune Checkpoint Inhibitors Features
    Figure 3. Monoclonal Antibodies Features
    Figure 4. Cytokine-Based Immunotherapy Features
    Figure 5. Cancer Vaccines Features
    Figure 6. CAR-T Cell Therapy Features
    Figure 7. Global Immuno-Oncology Treatment Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals Case Studies
    Figure 9. Ambulatory Surgical Center Case Studies
    Figure 10. Others Case Studies
    Figure 11. Immuno-Oncology Treatment Report Years Considered
    Figure 12. Global Immuno-Oncology Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Immuno-Oncology Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Immuno-Oncology Treatment Market Share by Regions: 2020 VS 2027
    Figure 15. Global Immuno-Oncology Treatment Market Share by Regions (2022-2027)
    Figure 16. Global Immuno-Oncology Treatment Market Share by Players in 2020
    Figure 17. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology Treatment as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2020
    Figure 19. Global Immuno-Oncology Treatment Revenue Market Share by Type (2016-2021)
    Figure 20. Global Immuno-Oncology Treatment Revenue Market Share by Type (2022-2027)
    Figure 21. North America Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Immuno-Oncology Treatment Market Share by Type (2016-2027)
    Figure 23. North America Immuno-Oncology Treatment Market Share by Application (2016-2027)
    Figure 24. North America Immuno-Oncology Treatment Market Share by Country (2016-2027)
    Figure 25. United States Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Immuno-Oncology Treatment Market Share by Type (2016-2027)
    Figure 29. Europe Immuno-Oncology Treatment Market Share by Application (2016-2027)
    Figure 30. Europe Immuno-Oncology Treatment Market Share by Country (2016-2027)
    Figure 31. Germany Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Immuno-Oncology Treatment Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Immuno-Oncology Treatment Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Immuno-Oncology Treatment Market Share by Region (2016-2027)
    Figure 41. China Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Immuno-Oncology Treatment Market Share by Type (2016-2027)
    Figure 49. Latin America Immuno-Oncology Treatment Market Share by Application (2016-2027)
    Figure 50. Latin America Immuno-Oncology Treatment Market Share by Country (2016-2027)
    Figure 51. Mexico Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Immuno-Oncology Treatment Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Immuno-Oncology Treatment Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Immuno-Oncology Treatment Market Share by Country (2016-2027)
    Figure 57. Turkey Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Immuno-Oncology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 61. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 63. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 64. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 66. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 67. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 68. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 69. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 70. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 71. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 72. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
Frequently Asked Questions
Immuno-Oncology Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immuno-Oncology Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immuno-Oncology Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bio Agriculture

Market Analysis and Insights: Global Bio Agriculture Market
The global Bio Agricult ... Read More

Sericulture

Market Analysis and Insights: Global Sericulture Market
The global Sericulture mark ... Read More